Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 28,640 | 27,357 | 4,252 | 2,138 | 957 |
| Cost of Goods | 4,627 | 1,985 | 3,160 | 2,615 | 2,895 |
| Gross Profit | 24,013 | 25,372 | 1,092 | -477 | -1,938 |
| Operating Expenses | 42,871 | 57,604 | 61,214 | 69,750 | 70,371 |
| Operating Income | -18,231 | -31,247 | -59,962 | -69,612 | -71,414 |
| Interest Expense | 1,262 | 1,153 | 1,176 | 1,395 | 1,378 |
| Other Income | 444 | 672 | 699 | 1,191 | 1,685 |
| Pre-tax Income | -19,049 | -31,728 | -60,439 | -69,816 | -71,107 |
| Income Tax | N/A | 24 | 11 | -19 | 1 |
| Net Income Continuous | -19,049 | -31,752 | -60,450 | -69,797 | -71,108 |
| Net Income | $-19,049 | $-31,752 | $-60,450 | $-69,797 | $-71,108 |
| EPS Basic Total Ops | -3.10 | -5.75 | -13.84 | -16.50 | -16.91 |
| EPS Basic Continuous Ops | -3.10 | -5.65 | -13.89 | -16.40 | -16.91 |
| EPS Diluted Total Ops | -3.10 | -5.75 | -13.84 | -16.50 | -16.91 |
| EPS Diluted Continuous Ops | -3.10 | -5.65 | -13.89 | -16.40 | -16.91 |
| EPS Diluted Before Non-Recurring Items | -3.10 | -5.75 | -14.00 | -16.50 | -17.00 |
| EBITDA(a) | $-16,911 | $-29,819 | $-56,645 | $-68,617 | $-70,968 |